Statistics
Publications
74
Citations
4.1K
H-Index
36
Active since
1987
Maja J.A. de Jonge is an author at Erasmus MC Cancer Institute specializing in pharmacology, medicine, and oncology.
Publications per year
1987–2023
74
74
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg et al. · Nature Medicine · 2023 · 298 citations · Full text
Medicine, Oncology, Pharmacology +16
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart et al. · Nature · 2019 · 269 citations · Full text
Medicine, Oncology, Pharmacology +10
Ferry A.L.M. Eskens, Francisco Javier Ramos, Herman Burger et al. · Clinical Cancer Research · 2013 · 250 citations · Full text
Medicine, Oncology, Pharmacology +14
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
J M W van Haarst, C. Manegold, J.H. Schouwink et al. · British Journal of Cancer · 2002 · 158 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 74